• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US UNK - IMPLANT; GENERAL INTERNAL ORTHOPAEDIC FIXATION SYSTEM IMPLANTATION KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US UNK - IMPLANT; GENERAL INTERNAL ORTHOPAEDIC FIXATION SYSTEM IMPLANTATION KIT Back to Search Results
Catalog Number UNK - IMPLANT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Patient codes: the code "no code available" was used to report the code "treatment failure." udi: unknown.The udi is unknown at this time.
 
Event Description
This report is being filed after the review of the following journal article: eajazi, a, et al (2013) comparison of different methods of femoral fixation anterior cruciate ligament reconstruction.Acta medica iranica, vol.51, pages 444-448 (iran).The study emphasizes on the comparison of three modes of femoral fixation, namely aperfix, rigidfix and endobutton, in anterior cruciate ligament (acl) reconstruction.120 patients were randomly assigned to three groups, each consisting of 40 patients, and each group was treated by one of the above mentioned methods of femoral fixation.All patients were examined prior to and 24 months after surgery, and they were compared for anterior tibial displacement using the lysholm score and kt-1000.The three modes of femoral fixation were not significantly different in terms of time of surgery.In the endobutton group, the lysholm score rose from 63.21±18.59 prior to acl reconstruction to 90.64±9.47 after the surgery, while it rose from 65.72±18.74 to 96.22±5.35 in the aperfix group and from 69.21±17.45 to 90.64±9.47 in the rigidfix group.Anterior tibial displacement was 3.96±1.58 mm for endobutton, 4.28±1.48 mm for rigidfix and 4.03±1.79 mm for aperfix.Aperfix was indicated to yield a better outcome in terms of instant stability and general results.The article describes the following procedure: all patients initially underwent diagnostic arthroscopy for evaluation of anterior and posterior cruciate ligaments as well as the medial and lateral menisci.Those patients whose acl rupture was confirmed on arthroscopy underwent surgery as follows: initially, an anteromedial incision was made on the proximal tibia and the gracilis and semitendinosus tendons were detached from their insertions on tibia.Subsequently, the tendons were removed to fashion the graft for acl reconstruction.A tibial canal was established; through this canal, the femoral canal was created under arthroscopy guide.Finally, the graft was passed through the canals as a single bundle.The device involved: rigidfix (depuy mitek, raynham, ma) complications mentioned in the case report were: there were 4 cases of failure in the rigidfix group.
 
Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by mitek or its employees that the report constitutes an admission that the device, mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.H10 additional narrative: investigation summary: the complaint device is not being returned, therefore unavailable for a physical evaluation.This complaint file was opened to document complaints derived through a journal article review.The journal article review indicated depuy mitek product failure(s).Multiple attempts were done to obtain more information from the author, however, no response was received.It is unknown if complaints derived from this journal article were previously reported and documented in the depuy mitek complaint system at the time of occurrence as no product code/lot number information was provided to perform the search.With the information provided, and without the complaint device to evaluate, we cannot determine a root cause for the reported problem.Since no lot number was provided, a manufacturing record evaluation could not be conducted.If any additional information is obtained, this complaint will be re-opened to capture that information.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - IMPLANT
Type of Device
GENERAL INTERNAL ORTHOPAEDIC FIXATION SYSTEM IMPLANTATION KIT
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
MDR Report Key10634542
MDR Text Key210229342
Report Number1221934-2020-02877
Device Sequence Number1
Product Code HTY
Combination Product (y/n)N
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 09/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue NumberUNK - IMPLANT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/20/2020
Initial Date FDA Received10/06/2020
Supplement Dates Manufacturer Received10/20/2020
Supplement Dates FDA Received10/21/2020
Patient Sequence Number1
-
-